POLE
Gene Information
- Official Symbol: POLE
- Official Name: DNA polymerase epsilon, catalytic subunit
- Aliases and Previous Symbols: N/A
- Entrez ID: 5426
- UniProt: Q07864
- Interactions: BioGRID
- PubMed articles: Open PubMed
- OMIM: Open OMIM
Function Summary
- Entrez Summary: This gene encodes the catalytic subunit of DNA polymerase epsilon. The enzyme is involved in DNA repair and chromosomal DNA replication. Mutations in this gene have been associated with colorectal cancer 12 and facial dysmorphism, immunodeficiency, livedo, and short stature. [provided by RefSeq, Sep 2013].
- UniProt Summary: Participates in DNA repair and in chromosomal DNA replication.
Pfam Domains GO Terms
Pfam Domains
| DNA pol B exo2 |
| DNA pol B |
| DUF1744 |
| DNA pol B exo1 |
GO Terms
| DNA replication proofreading |
| leading strand elongation |
| epsilon DNA polymerase complex |
| base-excision repair, gap-filling |
| single-stranded DNA 3-5 exodeoxyribonuclease activity |
| DNA strand elongation involved in DNA replication |
| DNA strand elongation |
| nucleotide-excision repair, DNA gap filling |
| telomere maintenance via semi-conservative replication |
| DNA-directed DNA polymerase activity |
| DNA replication initiation |
| base-excision repair |
| DNA-dependent DNA replication maintenance of fidelity |
| 4 iron, 4 sulfur cluster binding |
| nuclear DNA replication |
| cell cycle DNA replication |
| DNA synthesis involved in DNA repair |
| nucleotide binding |
| telomere maintenance |
| telomere organization |
| DNA biosynthetic process |
| nucleotide-excision repair |
| G1/S transition of mitotic cell cycle |
| DNA-dependent DNA replication |
| cell cycle G1/S phase transition |
| DNA replication |
| mitotic cell cycle phase transition |
| cell cycle phase transition |
| nucleic acid phosphodiester bond hydrolysis |
| anatomical structure homeostasis |
| chromatin binding |
| embryonic organ development |
| DNA repair |
| mitotic cell cycle process |
| mitotic cell cycle |
| DNA metabolic process |
| cellular response to DNA damage stimulus |
| zinc ion binding |
| cellular homeostasis |
| embryo development |
| cell cycle process |
| chromosome organization |
| nucleobase-containing compound biosynthetic process |
| heterocycle biosynthetic process |
| aromatic compound biosynthetic process |
| organic cyclic compound biosynthetic process |
| cell cycle |
| DNA binding |
| cellular nitrogen compound biosynthetic process |
| homeostatic process |
| cellular response to stress |
| cellular macromolecule biosynthetic process |
| macromolecule biosynthetic process |
CRISPR Data
Compound Hit Most Correlated Genes in Chemogenomics Tissues where Essential in the Avana Dataset (DepMap 20Q1)
Compound Hit
Most Correlated Genes in Chemogenomics
| Gene | Correlation |
|---|---|
| PSMD3 | 0.566 |
| CHD4 | 0.562 |
| PSMB2 | 0.548 |
| PRIM1 | 0.54 |
| TCEB3C | 0.537 |
| PSMB4 | 0.527 |
| TCEB3CL | 0.526 |
| PAN3 | 0.519 |
| NUPL1 | 0.518 |
| PSMA6 | 0.511 |
| POLR2J3 | 0.51 |
| PSMD2 | 0.508 |
| PDE4DIP | 0.507 |
| NUP160 | 0.507 |
| TCEB3CL2 | 0.505 |
| SUPT5H | 0.505 |
| C1QTNF9B | 0.504 |
| SLC4A1 | 0.503 |
| SART1 | 0.503 |
| RPL35 | 0.502 |
| PSMA7 | 0.501 |
| CBWD6 | 0.501 |
| PSMD7 | 0.5 |
| ATP6V1C1 | 0.499 |
| PSMD1 | 0.498 |
| CBWD5 | 0.497 |
| CDCA3 | 0.496 |
| DOCK6 | 0.494 |
| AATF | 0.493 |
| RAD51 | 0.491 |
| CBWD3 | 0.491 |
| CCNA2 | 0.491 |
| RRP15 | 0.489 |
| MDM2 | 0.488 |
| GOLGA6L3 | 0.487 |
| COPE | 0.484 |
| NHP2L1 | 0.484 |
| NPIPB5 | 0.483 |
| ZNF830 | 0.482 |
| ORC6 | 0.481 |
| GOLGA6L1 | 0.48 |
| RPS2 | 0.48 |
| TBC1D3H | 0.48 |
| UPF1 | 0.479 |
| CDC45 | 0.477 |
| TICRR | 0.476 |
| PSMD11 | 0.476 |
| TBC1D3F | 0.475 |
| MT1E | 0.474 |
| KCTD17 | 0.473 |
| IK | 0.472 |
| AAMP | 0.472 |
| PAF1 | 0.471 |
| ORC1 | 0.471 |
| RRP7A | 0.471 |
| PWP2 | 0.47 |
| DTL | 0.47 |
| GOLGA6A | 0.469 |
| COL2A1 | 0.467 |
| WDR75 | 0.467 |
| OSBP | 0.466 |
| POLR2F | 0.466 |
| RPS19BP1 | 0.464 |
| SNRPA1 | 0.463 |
| KRT78 | 0.463 |
| CCDC64B | 0.462 |
| IGFN1 | 0.461 |
| CGB2 | 0.461 |
| LAD1 | 0.459 |
| TYMS | 0.458 |
| TBC1D3 | 0.455 |
| NARFL | 0.454 |
| C14orf93 | 0.453 |
| STIL | 0.452 |
| ISCU | 0.45 |
| PSMC1 | 0.449 |
| TSG101 | 0.449 |
| RPS9 | 0.448 |
| MPHOSPH10 | 0.448 |
| RAD21 | 0.448 |
| EBNA1BP2 | 0.448 |
| LRR1 | 0.448 |
| HIST2H3A | 0.447 |
| CHAF1A | 0.447 |
| HIST2H3C | 0.447 |
| RRP1 | 0.446 |
| TBC1D3C | 0.446 |
| TFIP11 | 0.445 |
| TIMELESS | 0.445 |
| TBC1D3G | 0.444 |
| COPB1 | 0.443 |
| BYSL | 0.442 |
| MCOLN1 | 0.442 |
| GOLGA8O | 0.442 |
| NAPA | 0.441 |
| COPG1 | 0.441 |
| WDR43 | 0.441 |
| RPS4X | 0.44 |
| PSMC2 | 0.44 |
| ATP6V1A | 0.44 |
| ACSF2 | 0.44 |
| SAP30BP | 0.44 |
| ZFAND5 | 0.439 |
| DDTL | 0.439 |
| GID4 | 0.439 |
| DNTTIP2 | 0.437 |
| RPS12 | 0.437 |
| EXOSC5 | 0.436 |
| COPB2 | 0.436 |
| EXOSC9 | 0.435 |
| S1PR4 | 0.434 |
| INCENP | 0.434 |
| XYLT2 | 0.434 |
| CDC73 | 0.433 |
| VASN | 0.433 |
| SF3A1 | 0.433 |
| C3orf17 | 0.433 |
| FAM231C | 0.432 |
| PSMC6 | 0.431 |
| NUP205 | 0.431 |
| FAM231A | 0.431 |
| SLC6A17 | 0.431 |
| TSPY8 | 0.431 |
| PARP3 | 0.429 |
| TBC1D3I | 0.429 |
| TBC1D3E | 0.429 |
| ATP13A1 | 0.429 |
| TBC1D3L | 0.428 |
| NFATC4 | 0.428 |
| TBC1D3K | 0.428 |
| SLC7A6OS | 0.427 |
| RIOK2 | 0.427 |
| GPX4 | 0.426 |
| DDX56 | 0.426 |
| TP53TG3B | 0.424 |
| POLA1 | 0.424 |
| COX7A2L | 0.424 |
| MMS22L | 0.424 |
| NOL10 | 0.424 |
| NPIPB11 | 0.423 |
| NOP16 | 0.423 |
| NUP153 | 0.423 |
| TP53TG3 | 0.423 |
| ZNF574 | 0.423 |
| TP53TG3C | 0.423 |
| AQR | 0.423 |
| UQCRH | 0.422 |
| CHCHD3 | 0.421 |
| CKAP5 | 0.42 |
| DISP2 | 0.42 |
| PPFIA4 | 0.42 |
| CACTIN | 0.42 |
| SSH2 | 0.419 |
| VPS28 | 0.419 |
| RPSA | 0.419 |
| NOL12 | 0.419 |
| EXOSC6 | 0.419 |
| UTP20 | 0.418 |
| CACNA1A | 0.418 |
| TWISTNB | 0.418 |
| CROCC | 0.417 |
| PDCD11 | 0.417 |
| CDC6 | 0.417 |
| PSMB1 | 0.416 |
| KIAA0947 | 0.416 |
| FTSJ3 | 0.416 |
| MYLK3 | 0.416 |
| KIAA1211 | 0.415 |
| INTS5 | 0.415 |
| ZNF687 | 0.415 |
| BAGE2 | 0.414 |
| ANKLE2 | 0.414 |
| BAGE | 0.414 |
| PNO1 | 0.414 |
| FAM25B | 0.414 |
| BAGE3 | 0.414 |
| HIVEP3 | 0.413 |
| ADRM1 | 0.413 |
| BAGE4 | 0.413 |
| BAGE5 | 0.413 |
| UTP3 | 0.413 |
| RRN3 | 0.412 |
| GOLGA6L4 | 0.412 |
| PSMD8 | 0.412 |
| DHX38 | 0.412 |
| RPL7L1 | 0.412 |
| AKIRIN2 | 0.411 |
| MYT1L | 0.411 |
| ZNF541 | 0.411 |
| XAB2 | 0.411 |
| TP53TG3D | 0.409 |
| SMG1 | 0.409 |
| WDR46 | 0.409 |
| DNM2 | 0.409 |
| SH3BP1 | 0.409 |
| PAN2 | 0.408 |
| CEBPZ | 0.408 |
| ZNF655 | 0.408 |
| PLEKHA4 | 0.408 |
| PSMC5 | 0.407 |
| RPS5 | 0.407 |
| RPS3 | 0.406 |
| CDH24 | 0.406 |
| DDX21 | 0.405 |
| ACD | 0.405 |
| RANBP2 | 0.404 |
| MYH7B | 0.404 |
| SCMH1 | 0.403 |
| FBXW9 | 0.403 |
| NPIPB8 | 0.402 |
| MYO18A | 0.402 |
| AHCTF1 | 0.401 |
| POLA2 | 0.4 |
| PIGS | 0.4 |
| POLR2L | 0.4 |
Tissues where Essential in the Avana Dataset (DepMap 20Q1)
Global Fraction of Cell Lines Where Essential: 735/739
| Tissue | Fraction Of Cell Lines Where Essential |
|---|---|
| 1290807.0 | 1/1 |
| 909776.0 | 1/1 |
| bile duct | 28/28 |
| blood | 27/28 |
| bone | 26/26 |
| breast | 33/33 |
| central nervous system | 56/56 |
| cervix | 4/4 |
| colorectal | 16/17 |
| esophagus | 13/13 |
| fibroblast | 1/1 |
| gastric | 16/16 |
| kidney | 21/21 |
| liver | 20/20 |
| lung | 74/75 |
| lymphocyte | 16/16 |
| ovary | 26/26 |
| pancreas | 24/24 |
| peripheral nervous system | 16/16 |
| plasma cell | 15/15 |
| prostate | 1/1 |
| skin | 24/24 |
| soft tissue | 9/9 |
| thyroid | 2/2 |
| upper aerodigestive | 22/22 |
| urinary tract | 29/29 |
| uterus | 5/5 |
Essentiality in NALM6
- Essentiality Rank: 434
- Expression level (log2 read counts): 8.79
Expression Distribution
POLE Expression in NALM6 Cells: 8.79